Pilar Martı́n

5.4k total citations · 1 hit paper
74 papers, 3.6k citations indexed

About

Pilar Martı́n is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Pilar Martı́n has authored 74 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Immunology, 11 papers in Oncology and 8 papers in Surgery. Recurrent topics in Pilar Martı́n's work include T-cell and B-cell Immunology (30 papers), Immunotherapy and Immune Responses (27 papers) and Immune Cell Function and Interaction (21 papers). Pilar Martı́n is often cited by papers focused on T-cell and B-cell Immunology (30 papers), Immunotherapy and Immune Responses (27 papers) and Immune Cell Function and Interaction (21 papers). Pilar Martı́n collaborates with scholars based in Spain, United States and Germany. Pilar Martı́n's co-authors include Carlos Ardavı́n, Gloria Martı́nez del Hoyo, Francisco Sánchez‐Madrid, Fabienne Anjuère, Cristina Fernández-Arias, Héctor Hernández‐Vargas, Sara Ruiz, Jorge Moscat, María T. Díaz‐Meco and José R. Cortés and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Pilar Martı́n

73 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis

2024 33 citations Leslie T. Cooper, Bettina Heidecker et al. profile →

Peers

Countries citing papers authored by Pilar Martı́n

Since Specialization

Citations

This map shows the geographic impact of Pilar Martı́n's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilar Martı́n with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilar Martı́n more than expected).

Fields of papers citing papers by Pilar Martı́n

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pilar Martı́n. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilar Martı́n. The network helps show where Pilar Martı́n may publish in the future.

Co-authorship network of co-authors of Pilar Martı́n

This figure shows the co-authorship network connecting the top 25 collaborators of Pilar Martı́n. A scholar is included among the top collaborators of Pilar Martı́n based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pilar Martı́n. Pilar Martı́n is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T cells in cardiac health and disease 2025 ·Journal of Clinical Investigation ·Pilar Martı́n, Francisco Sánchez‐Madrid	14
2	Apolipoprotein E-ε2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study 2024 ·Circulation Research ·(unknown), (unknown), Juan Carlos Silla-Castro, Sergio Callejas, Belén Oliva, (unknown), Inés García‐Lunar, (unknown), José M. Ordovás, Pilar Martı́n, Fiona Blanco‐Kelly, Carmen Ayuso, Enrique Lara‐Pezzi, Antonio Fernández‐Ortíz, Ana García‐Álvarez, Ana Dopazo, Fátima Sánchez‐Cabo, Borja Ibáñez, Marta Cortés‐Canteli, Valentı́n Fuster	4
3	The inflammatory spectrum of cardiomyopathies 2024 ·Frontiers in Cardiovascular Medicine ·(unknown), Phillip Suwalski, (unknown), DeLisa Fairweather, Karin Klingel, Pilar Martı́n, Andrea Frustaci, Leslie T. Cooper, Thomas F. Lüscher, Ulf Landmesser, Bettina Heidecker	4
4	Update on the role of T cells in cognitive impairment 2023 ·British Journal of Pharmacology ·(unknown), Raquel Sánchez‐Díaz, (unknown), Pilar Martı́n	6
5	Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity 2023 ·Clinical & Translational Oncology ·Eduardo Zatarain‐Nicolás, Pilar Martı́n, Iván Márquez‐Rodas, Juan Antonio Virizuela, Ana Martín‐Garcia, Cristina Mitroi, Juan Cosı́n-Sales, Vivencio Barrios, Fátima Sánchez‐Cabo, Borja Ibáñez, Javier de Castro, Teresa López‐Fernández	4
6	Myocarditis following COVID ‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases 2022 ·European Journal of Heart Failure ·Bettina Heidecker, Noa Dagan, Ran D. Balicer, Urs Eriksson, Giuseppe Rosano, Andrew J.S. Coats, Carsten Tschöpe, Sebastian Kelle, Gregory A. Poland, Andrea Frustaci, Karin Klingel, Pilar Martı́n, Joshua M. Hare, Leslie T. Cooper, Antonis Pantazis, Massimo Imazio, Sanjay Prasad, Thomas F. Lüscher	84
7	Differential miRNAs in acute spontaneous coronary artery dissection: Pathophysiological insights from a potential biomarker 2021 ·EBioMedicine ·(unknown), David Adlam, Marcos García-Guimarães, Ancor Sanz‐García, (unknown), Fernando Rivero, Javier Cuesta, Teresa Bastante, (unknown), Alicia Vara, Enrique Martín‐Gayo, Miguel Vicente‐Manzanares, Pilar Martı́n, Nilesh J. Samani, Francisco Sánchez‐Madrid, Fernándo Alfonso, Hortensia de la Fuente	15
8	CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis 2016 ·Nature Immunology ·Danay Cibrián, María Laura Sáiz, Hortensia de la Fuente, Raquel Sánchez‐Díaz, Olga Moreno-Gonzalo, Inmaculada Jorge, Alessia Ferrarini, Jesús Vázquez, Carmen Punzón, Manuel Fresno, Miguel Vicente‐Manzanares, E. Daudén, Pedro M. Fernández‐Salguero, Pilar Martı́n, Francisco Sánchez‐Madrid	93
9	T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage 2015 ·BioMed Research International ·(unknown), Guadalupe Tirma Gónzalez-Mateo, Pedro Majano, (unknown), Marta Ruiz‐Ortega, Raquel Rodrigues‐Díez, Pilar Martı́n, Raquel Sánchez‐Díaz, Rafael Selgas, Manuel López‐Cabrera, (unknown)	14
10	Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression 2014 ·Journal of Autoimmunity ·José R. Cortés, Raquel Sánchez‐Díaz, (unknown), Olga Barreiro, (unknown), (unknown), Marı́a L. Toribio, Francisco Sánchez‐Madrid, Pilar Martı́n	70
11	IL-4 blocks TH1-polarizing/inflammatory cytokine gene expression during monocyte-derived dendritic cell differentiation through histone hypoacetylation 2013 ·Journal of Allergy and Clinical Immunology ·María López‐Bravo, (unknown), Pilar M. Domínguez, (unknown), Carlos del Fresno, Pilar Martı́n, Gloria Martı́nez del Hoyo, Carlos Ardavı́n	18
12	Th1/Th2 Differentiation and B Cell Function by the Atypical PKCs and Their Regulators 2012 ·Frontiers in Immunology ·Pilar Martı́n, Jorge Moscat	8
13	PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage 2010 ·Laboratory Investigation ·Pilar Sandoval, Jesús Loureiro, Guadalupe Tirma Gónzalez-Mateo, Marı́a Luisa Lozano, (unknown), José Antonio Sánchez-Tomero, Lorea Mendoza, Beatriz Santamaría, Alberto Ortíz, Marta Ruiz‐Ortega, Rafael Selgas, Pilar Martı́n, Francisco Sánchez‐Madrid, Abelardo Aguilera, Manuel López‐Cabrera	54
14	Functional Role of P-Selectin Glycoprotein Ligand 1/P-Selectin Interaction in the Generation of Tolerogenic Dendritic Cells 2007 ·The Journal of Immunology ·Ana Urzainqui, Gloria Martı́nez del Hoyo, Amalia Lamana, Hortensia de la Fuente, Olga Barreiro, Isabel M. Olazabal, Pilar Martı́n, Martin K. Wild, Dietmar Vestweber, Roberto González‐Amaro, Francisco Sánchez‐Madrid	71
15	Effects of surgical treatment on intellectual performance and memory in a Spanish sample of drug-resistant partial onset-temporal lobe epilepsy patients 2002 ·Seizure ·Pilar Martı́n, Fernando Maestú, Rafael G. Sola	17
16	Targeted Disruption of the ζPKC Gene Results in the Impairment of the NF-κB Pathway 2001 ·Molecular Cell ·Michael Leitges, Laura Sanz, Pilar Martı́n, Ángeles Durán, Uschi Braun, Juan F. Garcı́a, (unknown), María T. Díaz‐Meco, Paul D. Rennert, Jorge Moscat	319
17	Functional and phenotypic analysis of thymic B cells: role in the induction of T cell negative selection 1999 ·European Journal of Immunology ·Isabel Ferrero, Fabienne Anjuère, Pilar Martı́n, Gloria Martı́nez del Hoyo, Marta López‐Fraga, Natalia Wright, Rosa Varona, Gabriel Márquez, Carlos Ardavı́n	3
18	Functional and phenotypic analysis of thymic B cells: role in the induction of T cell negative selection 1999 ·European Journal of Immunology ·Isabel Ferrero, Fabienne Anjuère, Pilar Martı́n, Gloria Martı́nez del Hoyo, Marta López‐Fraga, Natalia Wright, Rosa Varona, Gabriel Márquez, Carlos Ardavı́n	47
19	Microsatellite instability and p53 mutations in sporadic right and left colon carcinoma 1998 ·Cancer ·Matilde E. Lleonart, Jesús García‐Foncillas, Ricardo Sánchez‐Prieto, Pilar Martı́n, Amália Moreno, Clara Salas, Santiago Ramón y Cajal	1
20	Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP‐3α¹ 1998 ·FEBS Letters ·Rosa Varona, Ángel Zaballos, Julio Gutiérrez, Pilar Martı́n, Fernando Roncal, Juan Pablo Albar, Carlos Ardavı́n, Gabriel Márquez	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact